This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Carlisle (CSL) Exhibits Strong Prospects, Risks Persist
by Zacks Equity Research
Carlisle (CSL) is poised to benefit from its exposure in diverse end markets, acquired assets and shareholder-friendly policies. However, soft end market and high debt level remain concerns.
Carlisle (CSL) Agrees to Divest CBF Segment to CentroMotion
by Zacks Equity Research
Carlisle's (CSL) sale of the CBF segment will help it simplify its portfolio and strengthen shareholder value. The divestment completion is expected in third-quarter 2021.
Carlisle (CSL) Moves 7.2% Higher: Will This Strength Last?
by Zacks Equity Research
Carlisle (CSL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Carlisle's (CSL) Q1 Earnings Top Estimates, Revenues Flat Y/Y
by Zacks Equity Research
Carlisle's (CSL) first-quarter 2021 revenues remain flat year over year on the back of weak performance across CIT segment. However, CCM, CFT and CBF units performed well.
Carlisle (CSL) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 116.18% and 5.45%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Carlisle (CSL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Icahn Enterprises (IEP) Prices $455M Senior Notes Offering
by Zacks Equity Research
Icahn Enterprises (IEP) prices senior notes offering. It intends to use net proceeds for the redemption of other senior notes that are due to mature in 2022.
Crane (CR) Share Price Increases 21% YTD: What's Driving It?
by Zacks Equity Research
Crane (CR), with a 21% increase in shares year to date, gains from solid product offering, improving market demand and growth investments. Also, acquired assets are advantageous.
Crane (CR) to Gain From End-Market Strength, Inorganic Moves
by Zacks Equity Research
Crane (CR) to gain from end-market strength, acquisitions, solid product offerings and efficient management team. Also, its policy of rewarding shareholders raises the stock's attractiveness.
Carlisle (CSL) Displays Bright Prospects Despite Persistent Risks
by Zacks Equity Research
Carlisle (CSL) to gain from a strong reroofing market, strength in the medical business, acquired assets and shareholder-friendly policies. Weakness in the commercial aerospace business is concerning.
Danaher (DHR) to Gain on Segmental Strength, Inorganic Actions
by Zacks Equity Research
Danaher (DHR) is poised to benefit from growth opportunities within its segments. Also, gains from acquired assets and divestments as well as shareholder-friendly policies are likely to favor.
Crane (CR) Hosts Annual Investor Day, Raises 2021 Projections
by Zacks Equity Research
Crane (CR) discusses strategic priorities for future growth at its annual investor day. It also provides its long-term view and talks about revision in projections for 2021.
Carlisle (CSL) Q4 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle's (CSL) fourth-quarter 2020 revenues fall 7% year over year on lackluster performance across CIT and CFT segments.
Carlisle (CSL) Beats Q4 Earnings Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 26.50% and -0.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Carlisle (CSL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Q4 Earnings Beat Estimates, Sales View Solid
by Zacks Equity Research
Danaher's (DHR) Q4 results reflect strength in Diagnostics, Life Sciences, and Environmental & Applied Solutions segments as well as growth in margins. Core sales growth projections are impressive.
Is Carlisle Companies (CSL) a Suitable Pick for Value Investors?
by Zacks Equity Research
Is Carlisle Companies (CSL) a great pick from the value investor's perspective right now? Read on to know more.
3M's (MMM) November Sales Improve Y/Y in High-Single Digits
by Zacks Equity Research
3M's (MMM) top-line performance in November reflects its improving segmental businesses and strength across geographies served. Foreign currency translation too benefits results.
Carlisle (CSL) to Benefit From Buyouts Amid Pandemic Scare
by Zacks Equity Research
Carlisle (CSL) is likely to benefit from its exposure in diverse end markets, acquired assets and focus on improving operational efficiencies. However, end markets remain weak.
Why Is Carlisle (CSL) Up 16.6% Since Last Earnings Report?
by Zacks Equity Research
Carlisle (CSL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day
by Zacks Equity Research
Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day
Bear of the Day: Carlisle (CSL)
by David Bartosiak
The stock is rocking but the earnings picture could be rolling over.
Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle Companies' (CSL) third-quarter 2020 revenues decline 12% year over year on account of lackluster performance across its segments.
Carlisle (CSL) Beats Q3 Earnings Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 11.49% and -0.36%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Carlisle (CSL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.